All stock lists
Dermata Therapeutics, Inc. (NASDAQ:DRMA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.76-0.02 (-2.43%)
Insider Score
––Not scored
DRMA Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
DRMA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 428.97 K | 1.54 M | 1.37 M | 1.26 M | 1.15 M | 1.06 M |
| R&D Expense | 212.56 K | 383.72 K | 526.62 K | 504.39 K | 617.84 K | 1.28 M |
| Operating Expenses | 3.01 M | 1.93 M | 1.90 M | 1.76 M | 1.77 M | 2.34 M |
| Operating Income | -3.01 M | -1.93 M | -1.90 M | -1.76 M | -1.77 M | -2.34 M |
| Pretax Income | -2.97 M | -1.85 M | -1.86 M | -1.69 M | -1.70 M | -2.30 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.97 M | -1.85 M | -1.86 M | -1.69 M | -1.70 M | -2.30 M |
| EPS (Basic) | -0.74 | -0.48 | -1.52 | -1.65 | -1.66 | -4.47 |
| EPS (Diluted) | -0.74 | -0.48 | -1.52 | -1.65 | -1.66 | -4.47 |
| Shares Outstanding | 4.02 M | 3.86 M | 1.22 M | 1.03 M | 1.03 M | 515.50 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.